$5 I think is with nothing except pediatric GvHD
On the negative side remember the company is about to start the Back pain trial, they have allready made the product and selected the hospitals in the trial. They mentioned database registeries like CIBMTR and NIH being interested in helping fund the trials, as well as cap raises.
They have their Dr octavious arms in every pie, as they should
But we know - it's most likely this discussion is mute, and in under 42 days - Approved for children at least.
From then on it's blastoff time!
$5 I think is with nothing except pediatric GvHDOn the negative...
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |